DK169344B1 - Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse - Google Patents

Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse Download PDF

Info

Publication number
DK169344B1
DK169344B1 DK434088A DK434088A DK169344B1 DK 169344 B1 DK169344 B1 DK 169344B1 DK 434088 A DK434088 A DK 434088A DK 434088 A DK434088 A DK 434088A DK 169344 B1 DK169344 B1 DK 169344B1
Authority
DK
Denmark
Prior art keywords
formula
compound
compound according
pharmaceutically acceptable
alkyl
Prior art date
Application number
DK434088A
Other languages
Danish (da)
English (en)
Other versions
DK434088A (da
DK434088D0 (da
Inventor
Mark G Saulnier
Peter D Senter
John F Kadow
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of DK434088D0 publication Critical patent/DK434088D0/da
Publication of DK434088A publication Critical patent/DK434088A/da
Application granted granted Critical
Publication of DK169344B1 publication Critical patent/DK169344B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)
DK434088A 1987-08-04 1988-08-03 Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse DK169344B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US8149387 1987-08-04
US19973188 1988-05-27
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (3)

Publication Number Publication Date
DK434088D0 DK434088D0 (da) 1988-08-03
DK434088A DK434088A (da) 1989-02-05
DK169344B1 true DK169344B1 (da) 1994-10-10

Family

ID=26765636

Family Applications (2)

Application Number Title Priority Date Filing Date
DK434088A DK169344B1 (da) 1987-08-04 1988-08-03 Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse
DK011992A DK11992A (da) 1987-08-04 1992-01-31 Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK011992A DK11992A (da) 1987-08-04 1992-01-31 Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse

Country Status (34)

Country Link
US (3) US4904768A (fr)
JP (1) JPH0699465B2 (fr)
KR (1) KR900006230B1 (fr)
CN (1) CN1027169C (fr)
AT (1) AT398974B (fr)
BE (1) BE1002982A4 (fr)
CA (1) CA1310637C (fr)
CH (1) CH676716A5 (fr)
CY (1) CY1625A (fr)
CZ (1) CZ286893B6 (fr)
DD (2) DD299067A5 (fr)
DE (1) DE3826562A1 (fr)
DK (2) DK169344B1 (fr)
ES (1) ES2010775A6 (fr)
FI (1) FI87790C (fr)
FR (1) FR2622193B1 (fr)
GB (1) GB2207674B (fr)
GR (1) GR1000490B (fr)
HK (1) HK6392A (fr)
HU (3) HU208147B (fr)
IE (1) IE61040B1 (fr)
IL (1) IL87290A (fr)
IT (1) IT1226825B (fr)
LU (2) LU87290A1 (fr)
MX (1) MX173843B (fr)
MY (1) MY104321A (fr)
NL (2) NL192683C (fr)
NO (4) NO170284C (fr)
NZ (1) NZ225615A (fr)
PT (1) PT88186B (fr)
SE (1) SE502214C2 (fr)
SG (1) SG101291G (fr)
SK (1) SK279325B6 (fr)
YU (3) YU143688A (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (fr) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JPH07632B2 (ja) * 1991-12-23 1995-01-11 ブリストル−マイヤーズ スクイブ カンパニー エトポシド４’−ホスフェート二ナトリウム塩の安定な六水和物
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
EP0835303A4 (fr) * 1995-06-07 2000-09-13 Univ Jefferson Agents antifongiques et leurs procedes d'identification et d'utlisation
AU726914B2 (en) * 1996-04-01 2000-11-23 Epix Pharmaceuticals, Inc. Bioactivated diagnostic imaging contrast agents
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (fr) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology DERIVES D'ACETAL DE 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
EP1438319A1 (fr) * 2001-10-26 2004-07-21 Centre National De La Recherche Scientifique (Cnrs) Derives d'etoposide, analogues et compositions pharmaceutiques contenant lesdits derives
KR20120068769A (ko) 2002-07-15 2012-06-27 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
WO2004060403A2 (fr) * 2003-01-06 2004-07-22 Angiochem Inc. Methode de transport d'un compose a travers une barriere sang/cerveau
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
RU2408605C2 (ru) * 2005-02-18 2011-01-10 Анджиокем Инк. Полипептид, способный преодолевать гематоэнцефалический барьер, и его конъюгат
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
ES2744225T3 (es) 2005-07-15 2020-02-24 Angiochem Inc Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8263644B2 (en) * 2007-09-13 2012-09-11 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
CA2705152C (fr) 2007-11-09 2016-10-11 Peregrine Pharmaceuticals, Inc. Compositions d'anticorps anti-vegf et procedes correspondants
EP2240475B1 (fr) 2007-12-20 2013-09-25 Novartis AG Dérivés de thiazole utilisés comme inhibiteur de la pi 3 kinase
MX355683B (es) * 2008-04-18 2018-04-26 Angiochem Inc Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
WO2010043049A1 (fr) 2008-10-15 2010-04-22 Angiochem Inc. Conjugués de l'étoposide et de la doxorubicine pour l'administration de médicaments
CA2740316A1 (fr) 2008-10-15 2010-04-22 Angiochem Inc. Conjugues d'agonistes de glp-1 et leurs utilisations
CA2745524C (fr) * 2008-12-05 2020-06-09 Angiochem Inc. Conjugues de neurotensine ou d'analogues de neurotensine et leurs applications
US8853353B2 (en) 2008-12-17 2014-10-07 Angiochem, Inc. Membrane type-1 matrix metalloprotein inhibitors and uses thereof
MX2011011023A (es) 2009-04-20 2012-01-20 Angiochem Inc Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
RU2012103240A (ru) 2009-07-02 2013-08-10 Ангиокем Инк. Мультимерные пептидные конъюгаты и их применение
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
EP2539337A1 (fr) 2010-02-22 2013-01-02 F. Hoffmann-La Roche AG Composés de pyrido[3,2-d]pyrimidine inhibiteurs de pi3k delta et procédés d'utilisation
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
MX343706B (es) 2011-01-31 2016-11-18 Novartis Ag Derivados heterocíclicos novedosos.
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
PT2771342T (pt) 2011-10-28 2016-08-17 Novartis Ag Derivados de purina e o seu uso no tratamento de doença
CA2855994A1 (fr) * 2011-12-09 2013-06-13 Demerx, Inc. Esters phosphoriques de noribogaine
WO2013173283A1 (fr) 2012-05-16 2013-11-21 Novartis Ag Régime posologique pour un inhibiteur de pi-3 kinase
CA2896133A1 (fr) 2012-12-20 2014-06-26 Demerx, Inc. Noribogaine substituee
CN105979947A (zh) 2013-12-06 2016-09-28 诺华股份有限公司 α-同工型选择性磷脂酰肌醇3-激酶抑制剂的剂量方案
EP3307326B9 (fr) 2015-06-15 2021-02-24 Angiochem Inc. Procédés de traitement d'une carcinomatose leptoméningée
RU2018119085A (ru) 2015-11-02 2019-12-04 Новартис Аг Схема введения ингибитора фосфатидилинозитол-3-киназы
WO2018060833A1 (fr) 2016-09-27 2018-04-05 Novartis Ag Schéma posologique pour l'alpelisib, un inhibiteur de la phosphatidylinositol 3-kinase spécifique de l'isoforme alpha
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (fr) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH544752A (de) * 1966-12-13 1974-01-15 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
EP0111058B1 (fr) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Procédé de préparation de 4'-déméthyl-épipodophyllotoxin-bêta-d-éthylidène-glucoside et dérivés acylés
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
IE61040B1 (en) 1994-09-07
JPH0699465B2 (ja) 1994-12-07
FI883596A7 (fi) 1989-02-05
CZ541288A3 (cs) 1999-12-15
SK541288A3 (en) 1998-10-07
MY104321A (en) 1994-03-31
NL192683B (fr) 1997-08-01
US4904768A (en) 1990-02-27
NL192683C (nl) 1997-12-02
IL87290A (en) 1993-01-31
NO170284C (no) 1992-09-30
NO170284B (no) 1992-06-22
DK434088A (da) 1989-02-05
NL8801934A (nl) 1989-03-01
CZ286893B6 (cs) 2000-07-12
DE3826562C2 (fr) 1993-04-08
KR900006230B1 (ko) 1990-08-27
MX173843B (es) 1994-03-30
DE3826562A1 (de) 1989-02-16
US5041424A (en) 1991-08-20
GR1000490B (el) 1992-07-30
IT8821535A0 (it) 1988-07-28
KR890003790A (ko) 1989-04-18
AT398974B (de) 1995-02-27
HK6392A (en) 1992-01-17
SE502214C2 (sv) 1995-09-18
NO883299D0 (no) 1988-07-26
IT1226825B (it) 1991-02-19
FI883596A0 (fi) 1988-08-01
IE882378L (en) 1989-02-04
CN1027169C (zh) 1994-12-28
NL970042I2 (fr) 2005-06-01
ATA195588A (de) 1994-07-15
PT88186A (pt) 1989-06-30
CY1625A (en) 1992-07-10
SK279325B6 (sk) 1998-10-07
NO920665L (no) 1989-02-24
NO172440B (no) 1993-04-13
HU208147B (en) 1993-08-30
YU10490A (en) 1990-06-30
FR2622193A1 (fr) 1989-04-28
NO920277L (no) 1989-02-24
FI87790C (fi) 1993-02-25
DK434088D0 (da) 1988-08-03
JPH01100188A (ja) 1989-04-18
GB8818462D0 (en) 1988-09-07
HU211960A9 (en) 1996-01-29
NO172440C (no) 1993-07-21
SG101291G (en) 1992-01-17
USRE35524E (en) 1997-06-03
GB2207674A (en) 1989-02-08
HU202547B (en) 1991-03-28
AU610619B2 (en) 1991-05-23
ES2010775A6 (es) 1989-12-01
NL970042I1 (nl) 1998-03-02
FI87790B (fi) 1992-11-13
AU2030688A (en) 1989-06-08
IL87290A0 (en) 1989-01-31
SE8802815L (sv) 1989-02-05
YU143688A (en) 1990-04-30
HU905862D0 (en) 1991-03-28
SE8802815D0 (sv) 1988-08-03
MX9202851A (es) 1992-06-30
BE1002982A4 (fr) 1991-10-15
PT88186B (pt) 1995-07-03
NO920277D0 (no) 1992-01-22
HUT47303A (en) 1989-02-28
DK11992D0 (da) 1992-01-31
NO920665D0 (no) 1992-02-20
GR880100512A (en) 1989-05-25
CA1310637C (fr) 1992-11-24
GB2207674B (en) 1991-09-11
LU87290A1 (fr) 1990-02-07
DD274423A5 (de) 1989-12-20
NO883299L (no) 1989-02-24
DD299067A5 (de) 1992-03-26
FR2622193B1 (fr) 1993-12-17
CH676716A5 (fr) 1991-02-28
LU90138I2 (fr) 1997-11-26
NZ225615A (en) 1991-06-25
YU10390A (en) 1990-06-30
NO1998002I1 (no) 1998-01-14
CN1061225A (zh) 1992-05-20
DK11992A (da) 1992-01-31

Similar Documents

Publication Publication Date Title
DK169344B1 (da) Epipodophyllotoxinglucosid-4'-phosphatderivater, deres anvendelse til fremstilling af antitumormidler, en fremgangsmåde til fremstilling af derivaterne samt farmaceutiske præparater indeholdende disse
AU772478B2 (en) Phosphoramidate, and mono-, DI-, and tri-phosphate esters of (1R,CIS)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1- methanol as antiviral agents
US5529989A (en) Pancratistatin prodrug
JPH10507462A (ja) エピポドフィロトキシンの水溶性誘導体、その製法、薬剤としてのその用途および抗癌治療におけるその意図的使用
US20080139509A1 (en) Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs
EP1585750A2 (fr) Promedicaments a base de narcistatine
CA2407606C (fr) Phosphoramidates bis-(n,n'-bis-(2-haloethyl)amino) comme agents antitumoraux
NO171728B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4'-demetylepipodofyllotoksin-glukosider
CN114644651A (zh) 芳氧基磷酰化氨基酸酯化合物的制备方法
WO2025174875A1 (fr) Composés antibactériens
US3622589A (en) A process for producing pyridoxine-4,5-cyclicmonophosphate
JP2005515958A (ja) パンクラチスタチンプロドラッグの合成

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired